These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 35005999

  • 1. Reasons for Intent to Discontinue and Remove Long-Acting Reversible Contraceptives: National Survey of Family Growth 2017-2019.
    Poleon S, Thompson EL.
    J Womens Health (Larchmt); 2022 May; 31(5):733-740. PubMed ID: 35005999
    [Abstract] [Full Text] [Related]

  • 2. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T, Habtu Y, Abreham B, Ayele M, Eliso M.
    Reprod Health; 2022 Feb 19; 19(1):47. PubMed ID: 35183214
    [Abstract] [Full Text] [Related]

  • 3. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z, Gao L, Anguzu R, Zhao J.
    Reprod Health; 2018 May 24; 15(1):85. PubMed ID: 29793501
    [Abstract] [Full Text] [Related]

  • 4. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A, Pilon D, Lynen R, Laliberté F, Gozalo L, Lefebvre P, Duh MS.
    Reprod Health; 2016 Aug 22; 13(1):96. PubMed ID: 27549429
    [Abstract] [Full Text] [Related]

  • 5. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
    Matusiewicz AK, Melbostad HS, Heil SH.
    Contraception; 2017 Nov 22; 96(5):365-369. PubMed ID: 28778423
    [Abstract] [Full Text] [Related]

  • 6. Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.
    Linton E, Mawson R, Hodges V, Mitchell CA.
    BMJ Sex Reprod Health; 2023 Oct 22; 49(4):282-292. PubMed ID: 36810206
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO, Masho SW.
    J Womens Health (Larchmt); 2018 Mar 22; 27(3):245-252. PubMed ID: 29148890
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Factors associated with early long-acting reversible contraceptives discontinuation in Ethiopia: evidence from the 2016 Ethiopian demographic and health survey.
    Fekadu GA, Omigbodun AO, Roberts OA, Yalew AW.
    Arch Public Health; 2020 Mar 22; 78():36. PubMed ID: 32626577
    [Abstract] [Full Text] [Related]

  • 11. The effect of mobile video training for healthcare providers on long-acting reversible contraceptive (LARC) use among adolescents and young women.
    Xiong W, Li C, Liu X, Gui T, Peng P.
    J Pediatr Adolesc Gynecol; 2021 Oct 22; 34(5):686-692. PubMed ID: 34023522
    [Abstract] [Full Text] [Related]

  • 12. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
    Lathrop E, Romero L, Hurst S, Bracero N, Zapata LB, Frey MT, Rivera MI, Berry-Bibee EN, Honein MA, Monroe J, Jamieson DJ.
    Lancet Public Health; 2018 Feb 22; 3(2):e91-e99. PubMed ID: 29371100
    [Abstract] [Full Text] [Related]

  • 13. Projections and opinions from 100 experts in long-acting reversible contraception.
    Foster DG, Barar R, Gould H, Gomez I, Nguyen D, Biggs MA.
    Contraception; 2015 Dec 22; 92(6):543-52. PubMed ID: 26515195
    [Abstract] [Full Text] [Related]

  • 14. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
    Eeckhaut MCW, Rendall MS, Zvavitch P.
    Demography; 2021 Aug 01; 58(4):1327-1346. PubMed ID: 34251428
    [Abstract] [Full Text] [Related]

  • 15. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S, Rajbhandary R, Lohani S.
    Matern Child Health J; 2017 Sep 01; 21(9):1713-1723. PubMed ID: 26955996
    [Abstract] [Full Text] [Related]

  • 16. Use of reproductive health services among women using long- or short-acting contraceptive methods - a register-based cohort study from Finland.
    Saloranta TH, Gyllenberg FK, But A, Gissler M, Heikinheimo O, Laine MK.
    BMC Public Health; 2022 Jun 14; 22(1):1185. PubMed ID: 35701805
    [Abstract] [Full Text] [Related]

  • 17. Urban-rural differences in attitudes and practices toward long-acting reversible contraceptives among family planning providers in Texas.
    Vaaler ML, Kalanges LK, Fonseca VP, Castrucci BC.
    Womens Health Issues; 2012 Mar 14; 22(2):e157-62. PubMed ID: 22265180
    [Abstract] [Full Text] [Related]

  • 18. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.
    Stancil SL, Miller MK, Duello A, Finocchario-Kessler S, Goggin K, Winograd RP, Hurley EA.
    Harm Reduct J; 2021 Aug 04; 18(1):83. PubMed ID: 34348734
    [Abstract] [Full Text] [Related]

  • 19. Social Determinants of Health and Patient-Reported Difficult Discontinuation of Long-Acting Reversible Contraception.
    Hall B, Evans TA, Atrio JM, Danvers AA.
    J Womens Health (Larchmt); 2024 Jul 22. PubMed ID: 39034886
    [Abstract] [Full Text] [Related]

  • 20. Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care.
    Jacinto A, Ronda AV, Lee C, Fikree FF, Ramirez-Ferrero E.
    Glob Health Sci Pract; 2022 Feb 28; 10(1):. PubMed ID: 35040804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.